Derivation of an induced pluripotent stem cell line (FDCHi014-A) from PBMCs of a seven-year-old patient with a truncating NOVA2 variant (c.625del)

Tingting Yin,Yanyan Qian,Xi Zhang,Yunfei Liao,Bingbing Wu,Sujuan Wang,Huijun Wang
DOI: https://doi.org/10.1016/j.scr.2024.103369
IF: 1.587
2024-02-01
Stem Cell Research
Abstract:Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities (NEDASB) is a rare autosomal dominant disorder caused by a heterozygous mutation in the NOVA2 gene on chromosome 19q13. Here, we describe the generation and characterization of an iPSC line derived from the peripheral blood of a 7-year-old patient carrying a novel heterozygous mutation in NOVA2 (c.625 del). The iPSCs with the confirmed patient-specific mutation were demonstrated by pluripotency markers, a normal karyotype, and the ability to differentiate into three germ layers. This NOVA2-mutant iPSC line could facilitate disease modeling and therapy development studies for NEDASB.
cell biology,biotechnology & applied microbiology,cell & tissue engineering
What problem does this paper attempt to address?